TH17 deficiency in human disease.

The Journal of Allergy and Clinical Immunology
Douglas R McDonald

Abstract

The differentiation of naive T cells into distinct subsets of effector T cells is critical for effective immunity against a wide variety of infectious agents in the environment. Activation of innate immune responses by Candida species through pattern-recognition receptors directs the subsequent development of naive T cells into T(H)17 cells, which are essential for effective mucosal immunity against fungi. Thorough analyses of cohorts of patients with unusual susceptibility to chronic mucocutaneous candidiasis resulting from T(H)17 deficiency have confirmed the role of T(H)17 cells and T(H)17 cytokines in human host defense against Candida species and have provided valuable insights into the complex process of T(H)17 cell development.

References

Oct 31, 1996·Nature·A K AbbasA Sher
Sep 15, 1998·Human Molecular Genetics·P BjörsesL Peltonen
Aug 23, 2002·Immunological Reviews·Rebecca H Buckley
Feb 27, 2004·Autoimmunity·Mary K CrowJay Wohlgemuth
Aug 4, 2004·Autoimmunity Reviews·Yael OppenheimYaron Tomer
Oct 16, 2004·Immunity·Jay K Kolls, Anders Lindén
Jan 22, 2005·Immunological Reviews·Bodo GrimbacherJennifer M Puck
Sep 4, 2007·Current Opinion in Immunology·Estelle BettelliVijay K Kuchroo
Sep 21, 2007·The New England Journal of Medicine·Steven M HollandBodo Grimbacher
Apr 11, 2008·Immunity·Mandy J McGeachy, Daniel J Cua
Jul 2, 2008·The Journal of Experimental Medicine·Cindy S MaMatthew C Cook
Jul 2, 2008·The Journal of Experimental Medicine·Ludovic de BeaucoudreyJean-Laurent Casanova
Jul 30, 2008·The Journal of Experimental Medicine·Nozomi TakahashiClaude Libert
Jan 10, 2009·Annual Review of Immunology·Thomas KornVijay K Kuchroo
Mar 31, 2009·Current Opinion in Immunology·Liang Zhou, Dan R Littman
Jun 3, 2009·The Journal of Experimental Medicine·Yoshiyuki MinegishiHajime Karasuyama
Jun 9, 2009·Current Opinion in Immunology·Xuyu ZhouJeffrey A Bluestone
Sep 25, 2009·The New England Journal of Medicine·Qian ZhangHelen C Su
Oct 30, 2009·The New England Journal of Medicine·Erik-Oliver GlockerBodo Grimbacher
Dec 17, 2009·The Journal of Allergy and Clinical Immunology·Karin R EngelhardtTalal A Chatila
Nov 9, 2010·Medicine·Capucine PicardJean-Laurent Casanova
Nov 16, 2010·Cytokine & Growth Factor Reviews·Simon VautierGordon D Brown
Nov 19, 2010·Cytokine & Growth Factor Reviews·Kiyoshi HiraharaJohn J O'Shea
Feb 26, 2011·Immunity·Yoichiro IwakuraSusumu Nakae
Jul 1, 2011·The New England Journal of Medicine·Frank L van de VeerdonkMihai G Netea
Jul 6, 2011·The Journal of Experimental Medicine·Luyan LiuJean-Laurent Casanova

❮ Previous
Next ❯

Citations

Feb 16, 2016·Vaccine·Jitendra Singh Rathore, Yan Wang
Sep 18, 2015·Immunity·James A Sanford, Richard L Gallo
Aug 19, 2015·Journal of Clinical Immunology·Tiphanie P VogelMegan A Cooper
Mar 20, 2016·Trends in Molecular Medicine·Bernard KanPascal M Lavoie
Apr 12, 2016·Seizure : the Journal of the British Epilepsy Association·Fen-Fen NiJia-Lun Wen
Aug 19, 2015·Journal of the American Academy of Dermatology·Dominique C PichardEdward W Cowen
Aug 19, 2015·Journal of the American Academy of Dermatology·Dominique C PichardEdward W Cowen
Sep 28, 2013·International Reviews of Immunology·Julien Verdier, Frank M Ruemmele
Oct 9, 2012·The Journal of Allergy and Clinical Immunology·László MaródiJean-Laurent Casanova
Feb 5, 2013·The Journal of Allergy and Clinical Immunology·Javier ChinenWilliam T Shearer
Jun 16, 2016·Allergology International : Official Journal of the Japanese Society of Allergology·Hidenori OhnishiToshiyuki Fukao
May 12, 2016·Journal of Medical Microbiology·Tomoaki NakagawaKazuhiro Tateda
Sep 16, 2016·Oral Diseases·M E PeacockC W Cutler
Jan 8, 2017·Annual Review of Pharmacology and Toxicology·Michael R Yeaman, John P Hennessey
Apr 4, 2014·Clinical Microbiology Reviews·Noah J Tubo, Marc K Jenkins
Apr 19, 2018·Frontiers in Immunology·Jose Antonio Tavares de AlbuquerqueAntonio Condino-Neto
Aug 2, 2019·Clinical Microbiology Reviews·Juarez Antonio Simões Quaresma
Jan 21, 2021·The Journal of Infectious Diseases·Andrea LiscoIrini Sereti
Oct 5, 2021·ACS Omega·Ankitha ShettyRiitta Lahesmaa
Nov 9, 2021·JCI Insight·Juan-Manuel Leyva-CastilloRaif S Geha

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.